Acute Lymphoblastic Leukemia Version 2.2025
Biliary Tract Cancers Version 2.2025
Colon Cancer Version 4.2025
Head and Neck Cancers Version 4.2025
Histiocytic Neoplasms Version 1.2025
Multiple Myeloma Version 1.2026
Myeloproliferative Neoplasms Version 2.2025
Non-Small Cell Lung Cancer Version 7.2025
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma Version 1.2026
NCCN Guidelines with Evidence Blocks - Acute Lymphoblastic Leukemia Version 2.2025
NCCN Guidelines with Evidence Blocks - Biliary Tract Cancers Version 2.2025
NCCN Guidelines with Evidence Blocks - Colon Cancer Version 4.2025
NCCN Guidelines with Evidence Blocks - Head and Neck Cancers Version 4.2025
NCCN Guidelines with Evidence Blocks - Histiocytic Neoplasms Version 1.2025
NCCN Guidelines with Evidence Blocks - Multiple Myeloma Version 1.2026
NCCN Guidelines with Evidence Blocks - Myeloproliferative Neoplasms Version 2.2025
NCCN Guidelines with Evidence Blocks - Non-Small Cell Lung Cancer Version 6.2025
NCCN Guidelines with Evidence Blocks - Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma Version 1.2026
Colorectal Cancer Screening Version 2.2025
Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate Version 1.2026
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric Version 1.2025
Prostate Cancer Early Detection Version 2.2025
Prevention and Treatment of Cancer-Related Infections Version 1.2025